Immunobiology – COST CA 16120 – EPITRAN

The proposed COST actions aims at fostering the development of the
emerging field of epitranscriptomics in Europe. We believe that, by
understanding the role of RNA modifications in physiology and pathology, novel and powerful disease biomarkers and drug targets could be identified
2017 – 2020

https://epitran.eu/